Original Research Online Published: 04 Jul 2024 | ||||||||||||
Comparative study of efficacy and safety profile of topical preparations of alcaftadine 0.25% and olopatadine 0.2% eye drops in patients of allergic conjunctivitis – A prospective cohort study Sushmma Kalla, Mahammad Jubair S, Monica N, Syed Atiq-Ur Rahman, Kandula Chaitanya, Nabita Subhani Misbah, Aqheel Ahmed, Akhila Prathi.
|
How to Cite this Article |
Pubmed Style Kalla S, S MJ, N M, Rahman SA, Chaitanya K, Misbah NS, Ahmed A, Prathi A. Comparative study of efficacy and safety profile of topical preparations of alcaftadine 0.25% and olopatadine 0.2% eye drops in patients of allergic conjunctivitis – A prospective cohort study. Natl J Physiol Pharm Pharmacol. 2024; 14(10): 2171-2176. doi:10.5455/njppp.2024.14.06260202428062024 Web Style Kalla S, S MJ, N M, Rahman SA, Chaitanya K, Misbah NS, Ahmed A, Prathi A. Comparative study of efficacy and safety profile of topical preparations of alcaftadine 0.25% and olopatadine 0.2% eye drops in patients of allergic conjunctivitis – A prospective cohort study. https://www.njppp.com/?mno=204742 [Access: November 01, 2024]. doi:10.5455/njppp.2024.14.06260202428062024 AMA (American Medical Association) Style Kalla S, S MJ, N M, Rahman SA, Chaitanya K, Misbah NS, Ahmed A, Prathi A. Comparative study of efficacy and safety profile of topical preparations of alcaftadine 0.25% and olopatadine 0.2% eye drops in patients of allergic conjunctivitis – A prospective cohort study. Natl J Physiol Pharm Pharmacol. 2024; 14(10): 2171-2176. doi:10.5455/njppp.2024.14.06260202428062024 Vancouver/ICMJE Style Kalla S, S MJ, N M, Rahman SA, Chaitanya K, Misbah NS, Ahmed A, Prathi A. Comparative study of efficacy and safety profile of topical preparations of alcaftadine 0.25% and olopatadine 0.2% eye drops in patients of allergic conjunctivitis – A prospective cohort study. Natl J Physiol Pharm Pharmacol. (2024), [cited November 01, 2024]; 14(10): 2171-2176. doi:10.5455/njppp.2024.14.06260202428062024 Harvard Style Kalla, S., S, . M. J., N, . M., Rahman, . S. A., Chaitanya, . K., Misbah, . N. S., Ahmed, . A. & Prathi, . A. (2024) Comparative study of efficacy and safety profile of topical preparations of alcaftadine 0.25% and olopatadine 0.2% eye drops in patients of allergic conjunctivitis – A prospective cohort study. Natl J Physiol Pharm Pharmacol, 14 (10), 2171-2176. doi:10.5455/njppp.2024.14.06260202428062024 Turabian Style Kalla, Sushmma, Mahammad Jubair S, Monica N, Syed Atiq-Ur Rahman, Kandula Chaitanya, Nabita Subhani Misbah, Aqheel Ahmed, and Akhila Prathi. 2024. Comparative study of efficacy and safety profile of topical preparations of alcaftadine 0.25% and olopatadine 0.2% eye drops in patients of allergic conjunctivitis – A prospective cohort study. National Journal of Physiology, Pharmacy and Pharmacology, 14 (10), 2171-2176. doi:10.5455/njppp.2024.14.06260202428062024 Chicago Style Kalla, Sushmma, Mahammad Jubair S, Monica N, Syed Atiq-Ur Rahman, Kandula Chaitanya, Nabita Subhani Misbah, Aqheel Ahmed, and Akhila Prathi. "Comparative study of efficacy and safety profile of topical preparations of alcaftadine 0.25% and olopatadine 0.2% eye drops in patients of allergic conjunctivitis – A prospective cohort study." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 2171-2176. doi:10.5455/njppp.2024.14.06260202428062024 MLA (The Modern Language Association) Style Kalla, Sushmma, Mahammad Jubair S, Monica N, Syed Atiq-Ur Rahman, Kandula Chaitanya, Nabita Subhani Misbah, Aqheel Ahmed, and Akhila Prathi. "Comparative study of efficacy and safety profile of topical preparations of alcaftadine 0.25% and olopatadine 0.2% eye drops in patients of allergic conjunctivitis – A prospective cohort study." National Journal of Physiology, Pharmacy and Pharmacology 14.10 (2024), 2171-2176. Print. doi:10.5455/njppp.2024.14.06260202428062024 APA (American Psychological Association) Style Kalla, S., S, . M. J., N, . M., Rahman, . S. A., Chaitanya, . K., Misbah, . N. S., Ahmed, . A. & Prathi, . A. (2024) Comparative study of efficacy and safety profile of topical preparations of alcaftadine 0.25% and olopatadine 0.2% eye drops in patients of allergic conjunctivitis – A prospective cohort study. National Journal of Physiology, Pharmacy and Pharmacology, 14 (10), 2171-2176. doi:10.5455/njppp.2024.14.06260202428062024 |